EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report
暂无分享,去创建一个
P. Lachenbruch | M. Bottai | J. Singh | M. Liang | L. Alfredsson | J. Vencovský | Taichi Hayashi | R. Barohn | B. Feldman | R. Cooper | V. Werth | F. Miller | C. Oddis | I. Lundberg | A. Amato | L. Rider | J. Katz | H. Kohsaka | P. Gordon | G. Santoni | M. Dimachkie | M. de Visser | S. Ytterberg | C. Pilkington | R. Aggarwal | H. Chinoy | L. Rutkowska-Sak | I. García-De La Torre | A. Reed | K. Dankó | B. Lang | S. Arnardóttir | A. Tjärnlund | H. Sanner | A. Selva-O’Callaghan | Yu-hui Li | Yeong Wook Song | Marzena Olesinka
[1] M. Guiguet,et al. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies , 2018, JAMA neurology.
[2] P. Lachenbruch,et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups , 2017, Annals of the rheumatic diseases.
[3] 中山 優吏佳. Cincinnati Children’s Hospital Medical Centerでの海外実習を終えて , 2017 .
[4] A. Martini,et al. Consensus procedures and their role in pediatric rheumatology , 2008, Current rheumatology reports.
[5] M. Dougados,et al. Classification criteria for rheumatic diseases: why and how? , 2007, Arthritis and rheumatism.
[6] M. Dougados,et al. Development of classification and response criteria for rheumatic diseases. , 2006, Arthritis and rheumatism.
[7] I. Targoff,et al. Novel Classification of Idiopathic Inflammatory Myopathies Based on Overlap Syndrome Features and Autoantibodies: Analysis of 100 French Canadian Patients , 2005, Medicine.
[8] A. Pestronk,et al. Polymyositis: An overdiagnosed entity , 2004, Neurology.
[9] R. Hughes,et al. 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands , 2004, Neuromuscular Disorders.
[10] H. Burger,et al. Polymyositis , 2003, Neurology.
[11] F. Mastaglia,et al. Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. , 2002, Rheumatic diseases clinics of North America.
[12] J. Habbema,et al. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. , 2001, Journal of clinical epidemiology.
[13] T. Medsger,et al. Classification criteria for the idiopathic inflammatory myopathies. , 1997, Current opinion in rheumatology.
[14] M. Dalakas,et al. Inclusion body myositis and myopathies , 1997, Journal of the Neurological Sciences.
[15] T. Sato,et al. Classification criteria for polymyositis and dermatomyositis. , 1995, The Journal of rheumatology.
[16] M. Dalakas. Polymyositis, dermatomyositis and inclusion-body myositis. , 1991, The New England journal of medicine.
[17] R. Brook,et al. Consensus methods: characteristics and guidelines for use. , 1984, American journal of public health.
[18] D. Rubin. INFERENCE AND MISSING DATA , 1975 .
[19] A. V. D. Ven,et al. The Effectiveness of Nominal, Delphi, and Interacting Group Decision Making Processes , 1974 .
[20] W. N. Dawson,et al. The epidemiology of polymyositis. , 1970, The American journal of medicine.
[21] H. Yoshida. Tokyo, Japan , 2019, The Statesman’s Yearbook Companion.
[22] Vicky Totikidis. Applying the Nominal Group Technique (NGT) in Community Based Action Research for Health Promotion and Disease Prevention , 2010 .
[23] T. Brannagan,et al. Polymyositis and dermatomyositis , 2002 .
[24] L. Breiman. Random Forests , 2001, Machine Learning.
[25] W. Bradley,et al. Polymyositis: its presentation, morbidity and mortality. , 1975, Brain : a journal of neurology.
[26] A. Bohan,et al. Polymyositis and dermatomyositis (second of two parts). , 1975, The New England journal of medicine.
[27] A. Bohan,et al. Polymyositis and dermatomyositis (first of two parts). , 1975, The New England journal of medicine.